clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Look Who’s Talking: Proteomic Biomarker Improves Preterm Birth Outcomes
News & Features
Viral Protein May Optimize Off-the-Shelf CAR T Cell Therapy
News & Features
Organoid Blood-Brain Barrier Could Improve Neurological Treatments
News & Features
NHS Launches Major AI Study for Breast Cancer Dx
News & Features
New Drug, CT-179, Holds Promise for Treating Medulloblastoma
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Home
Authors
Posts by Lisa Heiden, Ph.D.
Lisa Heiden, Ph.D.
2 POSTS
0 COMMENTS
Ph.D.
Molecular Dx
Cell-Free DNA Prospecting Starts to Pan Out
November 30, 2015
Molecular Dx
NGS Propels Personalized Oncology
April 1, 2015
Related Content
Look Who’s Talking: Proteomic Biomarker Improves Preterm Birth Outcomes
Efficacy of Cancer Immunotherapy Clarified by Computer Model
Can Transcriptomics Deliver New Markers of Prostate Cancer?
New Biomarker Predicts Severity of Post-COVID Effects
Inside Precision Medicine